133 related articles for article (PubMed ID: 37997516)
21. Serum Visfatin as a Diagnostic Marker of Active Inflammatory Bowel Disease.
Saadoun MM; Nosair NAE; Abdel-Azeez HA; Sharaf SM; Ahmed MH
J Gastrointestin Liver Dis; 2021 Sep; 30(3):339-345. PubMed ID: 34551033
[TBL] [Abstract][Full Text] [Related]
22. Neutrophil gelatinase-associated lipocalin (NGAL) in inflammatory bowel disease: association with pathophysiology of inflammation, established markers, and disease activity.
Oikonomou KA; Kapsoritakis AN; Theodoridou C; Karangelis D; Germenis A; Stefanidis I; Potamianos SP
J Gastroenterol; 2012 May; 47(5):519-30. PubMed ID: 22200942
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA ANRIL serves as a potential marker of disease risk, inflammation, and disease activity of pediatric inflammatory bowel disease.
Xia H; Li S; He Y; Ren Q; Qin S
Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101895. PubMed ID: 35227955
[TBL] [Abstract][Full Text] [Related]
24. Role of Altered Expression of miR-146a, miR-155, and miR-122 in Pediatric Patients with Inflammatory Bowel Disease.
Béres NJ; Szabó D; Kocsis D; Szűcs D; Kiss Z; Müller KE; Lendvai G; Kiss A; Arató A; Sziksz E; Vannay Á; Szabó AJ; Veres G
Inflamm Bowel Dis; 2016 Feb; 22(2):327-35. PubMed ID: 26752469
[TBL] [Abstract][Full Text] [Related]
25. Leucine-Rich Alpha-2 Glycoprotein Is a Reliable Serum Biomarker for Evaluating Clinical and Endoscopic Disease Activity in Inflammatory Bowel Disease.
Shimoyama T; Yamamoto T; Yoshiyama S; Nishikawa R; Umegae S
Inflamm Bowel Dis; 2023 Sep; 29(9):1399-1408. PubMed ID: 36334015
[TBL] [Abstract][Full Text] [Related]
26. Micro-RNAs -106a and -362-3p in Peripheral Blood of Inflammatory Bowel Disease Patients.
Omidbakhsh A; Saeedi M; Khoshnia M; Marjani A; Hakimi S
Open Biochem J; 2018; 12():78-86. PubMed ID: 30069249
[TBL] [Abstract][Full Text] [Related]
27. Differential Expression of microRNAs in Peripheral Blood Mononuclear Cells Identifies Autophagy and TGF-Beta-Related Signatures Aberrantly Expressed in Inflammatory Bowel Disease.
Mohammadi A; Kelly OB; Filice M; Kabakchiev B; Smith MI; Silverberg MS
J Crohns Colitis; 2018 Apr; 12(5):568-581. PubMed ID: 29420705
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of miR-595 and miR-1246 in the sera of patients with active forms of inflammatory bowel disease.
Krissansen GW; Yang Y; McQueen FM; Leung E; Peek D; Chan YC; Print C; Dalbeth N; Williams M; Fraser AG
Inflamm Bowel Dis; 2015 Mar; 21(3):520-30. PubMed ID: 25628040
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-320a Monitors Intestinal Disease Activity in Patients With Inflammatory Bowel Disease.
Cordes F; Demmig C; Bokemeyer A; Brückner M; Lenze F; Lenz P; Nowacki T; Tepasse P; Schmidt HH; Schmidt MA; Cichon C; Bettenworth D
Clin Transl Gastroenterol; 2020 Mar; 11(3):e00134. PubMed ID: 32352717
[TBL] [Abstract][Full Text] [Related]
30. Short noncoding RNAs as predictive biomarkers for the development from inflammatory bowel disease unclassified to Crohn's disease or ulcerative colitis.
James JP; Riis LB; Søkilde R; Malham M; Høgdall E; Langholz E; Nielsen BS
PLoS One; 2024; 19(2):e0297353. PubMed ID: 38408066
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-15a - cell division cycle 42 signaling pathway in pathogenesis of pediatric inflammatory bowel disease.
Tang WJ; Peng KY; Tang ZF; Wang YH; Xue AJ; Huang Y
World J Gastroenterol; 2018 Dec; 24(46):5234-5245. PubMed ID: 30581272
[TBL] [Abstract][Full Text] [Related]
32. Novel MicroRNA Signature to Differentiate Ulcerative Colitis from Crohn Disease: A Genome-Wide Study Using Next Generation Sequencing.
Lin J; Zhang X; Zhao Z; Welker NC; Li Y; Liu Y; Bronner MP
Microrna; 2016; 5(3):222-229. PubMed ID: 27855604
[TBL] [Abstract][Full Text] [Related]
33. Novel specific microRNA biomarkers in idiopathic inflammatory bowel disease unrelated to disease activity.
Lin J; Welker NC; Zhao Z; Li Y; Zhang J; Reuss SA; Zhang X; Lee H; Liu Y; Bronner MP
Mod Pathol; 2014 Apr; 27(4):602-8. PubMed ID: 24051693
[TBL] [Abstract][Full Text] [Related]
34. Circulating miR-125a but not miR-125b is decreased in active disease status and negatively correlates with disease severity as well as inflammatory cytokines in patients with Crohn's disease.
Sun CM; Wu J; Zhang H; Shi G; Chen ZT
World J Gastroenterol; 2017 Nov; 23(44):7888-7898. PubMed ID: 29209130
[TBL] [Abstract][Full Text] [Related]
35. An altered expression of miR-376a-3p and miR-20a-5p in peripheral blood exosomes regulates the autophagy and inflammatory systemic substrates, and relates to the smoking habit and age in Crohn's disease.
Caparrós E; García-Martinez I; Pedro Zapater ; Lucía Madero ; Valverde ÁM; Ana Gutiérrez ; Francés R
FASEB J; 2024 Jan; 38(2):e23418. PubMed ID: 38226870
[TBL] [Abstract][Full Text] [Related]
36. Platelet/Albumin ratio and plateletcrit levels are potential new biomarkers for assessing endoscopic inflammatory bowel disease severity.
Huang J; Lu J; Jiang F; Song T
BMC Gastroenterol; 2023 Nov; 23(1):393. PubMed ID: 37964205
[TBL] [Abstract][Full Text] [Related]
37. Circulating and Fecal microRNAs as Biomarkers for Inflammatory Bowel Diseases.
Schönauen K; Le N; von Arnim U; Schulz C; Malfertheiner P; Link A
Inflamm Bowel Dis; 2018 Jun; 24(7):1547-1557. PubMed ID: 29668922
[TBL] [Abstract][Full Text] [Related]
38. [Neopterin in assessing the activity of inflammatory bowel diseases: ulcerative colitis and Crohn's disease].
Ciećko-Michalska I; Fedak D; Mach T
Przegl Lek; 2010; 67(12):1262-5. PubMed ID: 21591350
[TBL] [Abstract][Full Text] [Related]
39. Identification of microRNA-16-5p and microRNA-21-5p in feces as potential noninvasive biomarkers for inflammatory bowel disease.
Zhou R; Qiu P; Wang H; Yang H; Yang X; Ye M; Wang F; Zhao Q
Aging (Albany NY); 2021 Feb; 13(3):4634-4646. PubMed ID: 33535181
[TBL] [Abstract][Full Text] [Related]
40. Fecal short chain fatty acids and urinary 3-indoxyl sulfate do not discriminate between patients with Crohn´s disease and ulcerative colitis and are not of diagnostic utility for predicting disease severity.
Tews HC; Elger T; Gunawan S; Fererberger T; Sommersberger S; Loibl J; Huss M; Liebisch G; Müller M; Kandulski A; Buechler C
Lipids Health Dis; 2023 Oct; 22(1):164. PubMed ID: 37789460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]